Skip to main content

Table 2 Site and type of non-serious and serious infections

From: Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists

 

Non-serious

Serious

Total

N (%)

N (%)

N (%)

 

318 (96.1)

13 (3.9)

331 (100)

Site of infection

   

Respiratory

120 (36.3)

7 (2.1)

127 (38.4)

Uro-genital

111 (33.5)

0

111 (33.5)

Skin and soft tissue

66 (20.0)

4 (1.2)

70 (21.2)

Gastrointestinal

21 (6.3)

0

21 (6.3)

Bone

0

2 (0.6)

2 (0.6)

Type of infection*

Bacterial*

236 (71.3)

12 (3.6)

248 (74.9)

Escherichia coli

40 (12.1)

0

40 (12.1)

Staphylococcus aureus

4 (1.2)

4 (1.2)

8 (2.4)

Proteus mirabilis

3 (0.9)

0

3 (0.9)

Klebsiella pneumoniae

2

0

2

Serratia marcescens

1

0

1

Yersinia spp

1

0

1

Chlamydia trachomatis

1

0

1

Viral*

61(18.4)

1

62 (18.7)

Herpes simplex

40 (12.1)

0

40 (12.1)

VZ virus

8 (2.4)

0

8 (2.4)

Fungal*

21 (7)

0

21 (7)

Candida albicans

5 (24)

0

5 (24)

Malassezia furfur

4 (19)

0

4 (19)

  1. *It was not possible to identify micro-organism for all infections.